ONLINE DATABASE SEARCH -
OI-LS-382-MEMO
1.
61572 OI-LS-382;
WOS-OI-8/24/2007
Cyclic Cidofovir (Chpmpc) Prevents Congenital Cytomegalovirus Infection
in a Guinea Pig Model
Schleiss, M., Anderson, J., and Mcgregor, A.
Virology Journal 2006.
3
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000247494800001
2.
61573 OI-LS-382;
EMBASE-OI-9/4/2007
Synthesis, biological activity, and SAR of antimycobacterial 2- and
8-substituted 6-(2-furyl)-9-(p-methoxybenzyl)purines
Braendvang, Morten and Gundersen, Lise-Lotte
Bioorganic & Medicinal Chemistry 2007. In Press, Corrected Proof:
6083
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6TF8-4PGGP0Y-9/2/f095dfa0ccdb8c542d480c3ee36982cd
3.
61574 OI-LS-382;
EMBASE-OI-9/4/2007
Synthesis and biological evaluation of a C5-biphenyl thiolactomycin
library
Bhowruth, Veemal, Brown, Alistair K, Senior, Suzanne J, Snaith, John S,
and Besra, Gurdyal S
Bioorganic & Medicinal Chemistry Letters 2007. In Press, Corrected Proof: 6083
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6TF9-4PGGP17-7/2/e1dfd03bf88c505069feb80360a270f1
4.
61575 OI-LS-382;
EMBASE-OI-9/4/2007
Synthesis and antitubercular activity of lipophilic moxifloxacin and
gatifloxacin derivatives
de Almeida, Mauro V, Saraiva, Mauricio F, de Souza, Marcus VN, da Costa,
Cristiane F, Vicente, Felipe RC, and Lourenco, Maria CS
Bioorganic & Medicinal Chemistry Letters 2007. In Press, Corrected Proof: 6083
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6TF9-4PG86YW-4/2/601c128cf3768a5a1f3b4d469b5fb32a
5.
61576 OI-LS-382;
EMBASE-OI-9/4/2007
Synthesis and antituberculosis activity of new thiazolylhydrazone
derivatives
Turan-Zitouni, Gulhan, Ozdemir, Ahmet, Asim Kaplancikli, Zafer, Benkli,
Kadriye, Chevallet, Pierre, and Akalin, Gulsen
European Journal of Medicinal Chemistry 2007. In Press, Corrected Proof:
173
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6VKY-4P6M7WK-4/2/a72cffbae32456e7a7fd6e1769de7de2
6.
61577 OI-LS-382;
EMBASE-OI-9/4/2007
Antimycobacterial activity of diphenylpyraline
derivatives
Weis, Robert, Faist, Johanna, di Vora, Ulrike, Schweiger, Klaus,
Brandner, Barbara, Kungl, Andreas J, and Seebacher, Werner
European Journal of Medicinal Chemistry 2007. In Press, Corrected Proof:
173
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6VKY-4P59WXV-6/2/1fe389b72dc1cb518a6ed27a5cb8e68c
7.
61578 OI-LS-382;
EMBASE-OI-9/4/2007
Phagocytic activity of alveolar macrophages toward polystyrene latex
microspheres and PLGA microspheres loaded with anti-tuberculosis
agent
Hasegawa, Taizo, Hirota, Keiji, Tomoda, Keishiro, Ito, Fuminori, Inagawa,
Hiroyuki, Kochi, Chie, Soma, Gen-Ichiro, Makino, Kimiko, and Terada,
Hiroshi
Colloids and Surfaces B: Biointerfaces 2007. In Press, Corrected Proof:
173
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6TFS-4P192G2-2/2/9ad081a7d4bd756eac468cb42f581c75
8.
61579 OI-LS-382;
EMBASE-OI-9/4/2007
Virulence of Mycobacterium avium in mice does not correlate with
resistance to nitric oxide
Lousada, Susana, Florido, Manuela, and Appelberg,
Rui
Microbial Pathogenesis 2007.
In Press, Corrected Proof: 113
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6WN6-4P40KJB-1/2/ebde061cd57f3f6b3261d186ba5582ba
9.
61580 OI-LS-382;
EMBASE-OI-9/4/2007
Cryptosporidium parvum spermidine/spermine N1-acetyltransferase exhibits
different characteristics from the host enzyme
Yarlett, Nigel, Wu, Gang, Waters, WRay, Harp, James A, Wannemuehler,
Michael J, Morada, Mary, Athanasopoulos, Demos, Martinez, Martha P, Upton, Steve
J, Marton, Laurence J, and Frydman, Benjamin J
Molecular and Biochemical Parasitology 2007. 152(2): 170-180
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6T29-4MSHXW6-2/2/976df31b16e0b97ca79537c210342edd
10.
61581 OI-LS-382;
EMBASE-OI-9/4/2007
Synthesis of chlorogenic acid derivatives with promising antifungal
activity
Ma, Chao-Mei, Kully, Maureen, Khan, Jehangir K, Hattori, Masao, and
Daneshtalab, Mohsen
Bioorganic & Medicinal Chemistry 2007. In Press, Corrected Proof:
1233
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6TF8-4PGGP0Y-F/2/395b904b5c2593ca239d289f004ce2ce
11.
61582 OI-LS-382;
WOS-OI-8/24/2007
Design, Synthesis, and Antifungal Activities of Novel 1h-Triazole
Derivatives Based on the Structure of the Active Site of Fungal Lanosterol 14
Alpha-Demethylase (Cyp51)
Zhao, Q. et al.
Chemistry & Biodiversity 2007. 4(7): 1472-1479
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000248370000005
12.
61583 OI-LS-382;
EMBASE-OI-9/4/2007
Nitazoxanide, tizoxanide and other thiazolides are potent inhibitors of
hepatitis B virus and hepatitis C virus replication
Korba, Brent E, Mueller, Abigail B, Farrar, Kristine, Gaye, Karen,
Mukerjee, Sampa, Ayers, Marc S, and Rossignol,
Jean-Francois
Antiviral Research 2007.
In Press, Uncorrected Proof: 5149
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6T2H-4PK8K5F-2/2/207706b6ee0c8fac1bdfa00b56c78c09
13.
61584 OI-LS-382;
EMBASE-OI-9/4/2007
Novel Potent Macrocyclic Inhibitors of the Hepatitis C Virus NS3
Protease. Use of Cyclopentane and Cyclopentene P2-Motifs
Back, Marcus, Johansson, Per-Ola, Wangsell, Fredrik, Thorstensson,
Fredrik, Kvarnstrom, Ingemar, Alvarez, Susana Ayesa, Wahling, Horst, Pelcman,
Mikael, Jansson, Katarina, Lindstrom, Stefan, Wallberg, Hans, Classon, Bjorn,
Rydergard, Christina, Vrang, Lotta, Hamelink, Elizabeth, Hallberg, Anders,
Rosenquist, Asa, and Samuelsson, Bertil
Bioorganic & Medicinal Chemistry 2007. In Press, Accepted Manuscript:
1367
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6TF8-4PGGP0Y-6/2/6647437477a6490e810c6c29082b0c67
14.
61585 OI-LS-382;
PUBMED-OI-9/4/2007
5'-O-Masked 2'-deoxyadenosine analogues as lead compounds for hepatitis C
virus (HCV) therapeutic agents
Ikejiri, M, Ohshima, T, Kato, K, Toyama, M, Murata, T, Shimotohno, K, and
Maruyama, T
Bioorg Med Chem 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
15.
61586 OI-LS-382;
PUBMED-OI-9/4/2007
Design, synthesis and antitubercular activity of diarylmethylnaphthol
derivatives
Das, SK, Panda, G, Chaturvedi, V, Manju, YS, Gaikwad, AK, and Sinha,
S
Bioorg Med Chem Lett 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
16.
61587 OI-LS-382;
PUBMED-OI-9/4/2007
Impact of NS5A Sequences of Hepatitis C Virus Genotype 1a on Early Viral
Kinetics during Treatment with Peginterferon- alpha 2a Plus
Ribavirin
Dal Pero, F, Tang, KH, Gerotto, M, Bortoletto, G, Paulon, E, Herrmann, E,
Zeuzem, S, Alberti, A, and Naoumov, NV
J Infect Dis 2007.
196(7): 998-1005
View Data on the NIAID Therapeutics Website
HYPERLINK:
17.
61588 OI-LS-382;
PUBMED-OI-9/4/2007
Identification of acetylated, tetrahalogenated benzimidazole
D-ribonucleosides with enhanced activity against human
cytomegalovirus
Hwang, JS, Kregler, O,
Schilf, R, Bannert, N, Drach, JC, Townsend, LB, and Bogner,
E
J Virol 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
18.
61589 OI-LS-382;
PUBMED-OI-9/4/2007
Concentration-dependent Mycobacterium tuberculosis killing and prevention
of resistance by rifampin
Gumbo, T, Louie, A, Deziel, MR, Liu, W, Parsons, LM, Salfinger, M, and
Drusano, GL
Antimicrob Agents Chemother 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
19.
61590 OI-LS-382;
PUBMED-OI-9/4/2007
The farnesyl diphosphate/geranylgeranyl diphosphate synthase of
toxoplasma gondii is a bifunctional enzyme and a molecular target of
bisphosphonates
Ling, Y, Li, ZH, Miranda, K, Oldfield, E, and Moreno,
SN
J Biol Chem 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
20.
61591 OI-LS-382;
PUBMED-OI-9/4/2007
Synthesis and antimicrobial evaluation of new chalcones containing
piperazine or 2,5-dichlorothiophene
moiety
Tomar, V, Bhattacharjee, G, Kamaluddin, and Ashok,
Kumar
Bioorg Med Chem Lett 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
21.
61592 OI-LS-382;
PUBMED-OI-9/4/2007
In Vitro and In Vivo Activities of Novel Fluoroquinolones Alone and in
Combination with Clarithromycin against Clinically Isolated Mycobacterium avium
complex Strains in Japan
Kohno, Y, Ohno, H, Miyazaki, Y, Higashiyama, Y, Yanagihara, K, Hirakata,
Y, Fukushima, K, and Kohno, S
Antimicrob Agents Chemother 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
22.
61593 OI-LS-382;
PUBMED-OI-9/4/2007
Comparative aspects on the role of polypyrimidine tract-binding protein
in internal initiation of hepatitis C virus and picornavirus
RNAs
Nishimura, T, Saito, M, Takano, T, Nomoto, A, Kohara, M, and
Tsukiyama-Kohara, K
Comp Immunol Microbiol Infect Dis 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
23.
61594 OI-LS-382;
PUBMED-OI-9/4/2007
Adverse drug reactions associated with first-line anti-tuberculosis drug
regimens
Marra, F, Marra, CA, Bruchet, N, Richardson, K, Moadebi, S, Elwood, RK,
and Fitzgerald, JM
Int J Tuberc Lung Dis 2007.
11(8): 868-75
View Data on the NIAID Therapeutics Website
HYPERLINK:
24.
61595 OI-LS-382;
PUBMED-OI-9/4/2007
A New Series of 3-Alkyl Phosphate Derivatives of
4,5,6,7-Tetrahydro-1-d-ribityl-1H-pyrazolo[3,4-d]pyrimidinedione as Inhibitors
of Lumazine Synthase: Design, Synthesis, and Evaluation
Zhang, Y, Jin, G, Illarionov, B, Bacher, A, Fischer, M, and Cushman,
M
J Org Chem 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
25.
61596 OI-LS-382;
PUBMED-OI-9/4/2007
Anti-hepatitis C virus activity of tamoxifen reveals the functional
association of estrogen receptor with viral RNA polymerase NS5B
Watashi, K, Inoue, D, Hijikata, M, Goto, K, Aly, HH, and Shimotohno,
K
J Biol Chem 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
26.
61597 OI-LS-382;
PUBMED-OI-9/4/2007
Additive effect of ethanol and HCV subgenomic replicon expression on
COX-2 protein levels and activity
Trujillo-Murillo, K, Alvarez-Martinez, O, Garza-Rodriguez, L,
Martinez-Rodriguez, H, Bosques-Padilla, F, Ramos-Jimenez, J, Barrera-Saldana, H,
Rincon-Sanchez, AR, and Rivas-Estilla, AM
J Viral Hepat 2007.
14(9): 608-17
View Data on the NIAID Therapeutics Website
HYPERLINK:
27.
61598 OI-LS-382;
PUBMED-OI-9/4/2007
Biological evaluations of fatty acid esters originated during storage of
Prasaplai, a Thai traditional medicine
Tangyuenyongwatana, P and Gritsanapan, W
Nat Prod Res 2007.
21(11): 990-7
View Data on the NIAID Therapeutics Website
HYPERLINK:
28.
61599 OI-LS-382;
PUBMED-OI-9/4/2007
Nuclear factors are involved in hepatitis C virus RNA
replication
Isken, O, Baroth, M, Grassmann, CW, Weinlich, S, Ostareck, DH,
Ostareck-Lederer, A, and Behrens, SE
RNA 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
29.
61600 OI-LS-382;
PUBMED-OI-9/4/2007
How pantothenol intervenes in Coenzyme-A biosynthesis of Mycobacterium
tuberculosis
Kumar, P, Chhibber, M, and Surolia, A
Biochem Biophys Res Commun 2007. 361(4): 903-9
View Data on the NIAID Therapeutics Website
HYPERLINK:
30.
61601 OI-LS-382;
PUBMED-OI-9/4/2007
Fumagillin: an anti-infective as a parent molecule for novel angiogenesis
inhibitors
Lefkove, B, Govindarajan, B, and Arbiser, JL
Expert Rev Anti Infect Ther 2007. 5(4): 573-9
View Data on the NIAID Therapeutics Website
HYPERLINK:
31.
61602 OI-LS-382;
PUBMED-OI-9/4/2007
Cutting Edge: Vitamin D-Mediated Human Antimicrobial Activity against
Mycobacterium tuberculosis Is Dependent on the Induction of
Cathelicidin
Liu, PT, Stenger, S, Tang, DH, and Modlin, RL
J Immunol 2007.
179(4): 2060-3